BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 21385260)

  • 21. Epilepsy and the natural history of Rett syndrome.
    Glaze DG; Percy AK; Skinner S; Motil KJ; Neul JL; Barrish JO; Lane JB; Geerts SP; Annese F; Graham J; McNair L; Lee HS
    Neurology; 2010 Mar; 74(11):909-12. PubMed ID: 20231667
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotypies in Rett syndrome: analysis of 83 patients with and without detected MECP2 mutations.
    Temudo T; Oliveira P; Santos M; Dias K; Vieira J; Moreira A; Calado E; Carrilho I; Oliveira G; Levy A; Barbot C; Fonseca M; Cabral A; Dias A; Cabral P; Monteiro J; Borges L; Gomes R; Barbosa C; Mira G; Eusébio F; Santos M; Sequeiros J; Maciel P
    Neurology; 2007 Apr; 68(15):1183-7. PubMed ID: 17420401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and genotypic variability in four males with MECP2 gene sequence aberrations including a novel deletion.
    Psoni S; Sofocleous C; Traeger-Synodinos J; Kitsiou-Tzeli S; Kanavakis E; Fryssira-Kanioura H
    Pediatr Res; 2010 May; 67(5):551-6. PubMed ID: 20098342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methyl-CpG binding protein 2 gene (MECP2) variations in Japanese patients with Rett syndrome: pathological mutations and polymorphisms.
    Fukuda T; Yamashita Y; Nagamitsu S; Miyamoto K; Jin JJ; Ohmori I; Ohtsuka Y; Kuwajima K; Endo S; Iwai T; Yamagata H; Tabara Y; Miki T; Matsuishi T; Kondo I
    Brain Dev; 2005 Apr; 27(3):211-7. PubMed ID: 15737703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for abnormal early development in a mouse model of Rett syndrome.
    Santos M; Silva-Fernandes A; Oliveira P; Sousa N; Maciel P
    Genes Brain Behav; 2007 Apr; 6(3):277-86. PubMed ID: 16848781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The story of Rett syndrome: from clinic to neurobiology.
    Chahrour M; Zoghbi HY
    Neuron; 2007 Nov; 56(3):422-37. PubMed ID: 17988628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autonomic dysfunction with mutations in the gene that encodes methyl-CpG-binding protein 2: insights into Rett syndrome.
    Lioy DT; Wu WW; Bissonnette JM
    Auton Neurosci; 2011 Apr; 161(1-2):55-62. PubMed ID: 21316312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of mutation type and location on phenotype in 123 patients with Rett syndrome.
    Huppke P; Held M; Hanefeld F; Engel W; Laccone F
    Neuropediatrics; 2002 Apr; 33(2):63-8. PubMed ID: 12075485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent insights into genotype-phenotype relationships in patients with Rett syndrome using a fine grain scale.
    Fabio RA; Colombo B; Russo S; Cogliati F; Masciadri M; Foglia S; Antonietti A; Tavian D
    Res Dev Disabil; 2014 Nov; 35(11):2976-86. PubMed ID: 25124696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE epsilon4: a potential modulation factor in Rett syndrome.
    Zahorakova D; Jachymova M; Kemlink D; Baxova A; Martasek P
    J Child Neurol; 2010 May; 25(5):546-50. PubMed ID: 20139413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive and social functions and growth factors in a mouse model of Rett syndrome.
    Schaevitz LR; Moriuchi JM; Nag N; Mellot TJ; Berger-Sweeney J
    Physiol Behav; 2010 Jun; 100(3):255-63. PubMed ID: 20045424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive value of the early clinical signs in Rett disorder.
    Kerr AM; Prescott RJ
    Brain Dev; 2005 Nov; 27 Suppl 1():S20-S24. PubMed ID: 16182500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MECP2 mutations in Czech patients with Rett syndrome and Rett-like phenotypes: novel mutations, genotype-phenotype correlations and validation of high-resolution melting analysis for mutation scanning.
    Zahorakova D; Lelkova P; Gregor V; Magner M; Zeman J; Martasek P
    J Hum Genet; 2016 Jul; 61(7):617-25. PubMed ID: 26984561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
    Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface- and voxel-based brain morphologic study in Rett and Rett-like syndrome with MECP2 mutation.
    Shiohama T; Levman J; Takahashi E
    Int J Dev Neurosci; 2019 Apr; 73():83-88. PubMed ID: 30690146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical profiles of four patients with Rett syndrome carrying a novel exon 1 mutation or genomic rearrangement in the MECP2 gene.
    Bartholdi D; Klein A; Weissert M; Koenig N; Baumer A; Boltshauser E; Schinzel A; Berger W; Mátyás G
    Clin Genet; 2006 Apr; 69(4):319-26. PubMed ID: 16630165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.